Browse > Article
http://dx.doi.org/10.14475/kjhpc.2017.20.1.18

Physician's Attitude toward Treating Breakthrough Cancer Pain in Korea  

Seo, Min Seok (Department of Family Medicine, Incheon St. Mary Hospital, The Catholic University of Korea College of Medicine)
Shim, Jae Yong (Department of Family Medicine, Severance Hospital, Yonsei University of College of Medicine)
Choi, Youn Seon (Korea University Guro Hospital)
Kim, Do Yeun (Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine)
Hwang, In Gyu (Chung-Ang University College of Medicine)
Baek, Sun Kyung (Kyung Hee University Hospital, Kyung Hee University College of Medicine)
Shin, Jin Young (Supportive Care Center, Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University College of Medicine)
Lee, Juneyoung (Department of Biostatistics, Korea University College of Medicine)
Lee, Chang Geol (Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine)
Publication Information
Journal of Hospice and Palliative Care / v.20, no.1, 2017 , pp. 18-25 More about this Journal
Abstract
Purpose: Adequate control of breakthrough pain is essential for patients with cancer. Managing breakthrough pain mainly depends on understanding the concept of breakthrough pain and the proper usage of rescue medication by physicians. This study aims to assess the attitudes and practice patterns of palliative physicians in managing breakthrough pain for patients in Korea. Methods: This study was based on data from the 2014 breakthrough cancer pain survey conducted by the Korean Society for Hospice and Palliative Care. One hundred physicians participated in the online survey. Among total 33 self-reported questionnaires, twelve items were selected in this analysis. Results: Rapid onset of action is the main influencing factor in selecting rescue opioids. Oral oxycodone (65%) and parenteral morphine (27%) are commonly used. A few physicians (3%) prefer to use transmucosal fentanyl. The percentage of physicians prescribing oral oxycodone due to its rapid onset of action is just 21.5%, whereas the percentage of physicians using parenteral morphine is 81.5%. Two thirds of respondents (66%) answered that breakthrough pain is not well controlled with rescue medications. Conclusion: There is a gap between the needs of physicians in terms of the perceived difficulties of managing breakthrough cancer pain and their practice patterns selecting rescue medications.
Keywords
Breakthrough pain; Palliative care; Opioid analgesics;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Kim do Y, Ahn JS, Lee KH, Kim YC, Lee J, Kim SY. A nationwide survey of knowledge of and compliance with cancer pain management guidelines by Korean physicians. Cancer Res Treat 2014;46:131-40.   DOI
2 Wengstrom Y, Rundstrom C, Geerling J, Pappa T, Weisse I, Williams SC, et al. The management of breakthrough cancer pain-educational needs a European nursing survey. Eur J Cancer Care (Engl) 2014;23:121-8.   DOI
3 Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012;13:e58-68.   DOI
4 British Columbia. Guidelines & protocols: Palliative care for the patient with incurable cancer or advanced disease - Part 2: Pain and symptom management [Internet]. Victoria, B. C.; Province of British Columbia; 2011 [cited 2015 Jan 5]. Available from: http://www.bcguidelines.ca/guideline_palliative2.html.
5 Doulton B. Pharmacologic management of adult breakthrough cancer pain. Can Fam Physician. 2014;60:1111-4.
6 Ministry of Health and Welfare, National Cancer Center. Cancer pain management guideline [Internet]. 6th ed. Sejong, Goyang: Ministry of Health and Welfare, National Cancer Center; 2015 [cited 2016 Apr 19]. Available from: http://www.cancer.go.kr/ebook/135/PC/135.html.
7 Hong SH, Roh SY, Kim SY, Shin SW, Kim CS, Choi JH, et al. Change in cancer pain management in Korea between 2001 and 2006: results of two nationwide surveys. J Pain Symptom Manage 2011;41:93-103.   DOI
8 Song JD, Lee SH, Jo KW. An Analysis of Relative Importance among Prescription Criteria Using the AHP (Analytic Hierarchy Process). Korean J Health Econ Policy 2013;19:99-127.
9 Davies AN, Dickman A, Reid C, Stevens AM, Zeppetella G; Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain 2009;13:331-8.   DOI
10 Deandrea S, Corli O, Consonni D, Villani W, Greco MT, Apolone G. Prevalence of breakthrough cancer pain: a systematic review and a pooled analysis of published literature. J Pain Symptom Manage 2014;47:57-76.   DOI
11 Webber K, Davies AN, Cowie MR. Breakthrough pain: a qualitative study involving patients with advanced cancer. Support Care Cancer 2011;19:2041-6.   DOI
12 Yates PM, Edwards HE, Nash RE, Walsh AM, Fentiman BJ, Skerman HM, et al. Barriers to effective cancer pain management: a survey of hospitalized cancer patients in Australia. J Pain Symptom Manage 2002;23:393-405.   DOI
13 Fortner BV, Okon TA, Portenoy RK. A survey of pain-related hospitalizations, emergency department visits, and physician office visits reported by cancer patients with and without history of breakthrough pain. J Pain 2002;3:38-44.
14 Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009;20:1420-33.   DOI
15 Oldenmenger WH, Sillevis Smitt PA, van Dooren S, Stoter G, van der Rijt CC. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal. Eur J Cancer 2009;45:1370-80.   DOI
16 Bennett D, Burton AW, Fishman S, Fortner B, McCarberg B, Miaskowski C, et al. Consensus panel recommendations for the assessment and management of breakthrough pain. Part 2: management. P & T 2005;30:354-61.
17 Zeppetella G. Opioids for the management of breakthrough cancer pain in adults: a systematic review undertaken as part of an EPCRC opioid guidelines project. Palliat Med 2011;25:516-24.   DOI
18 Davies AN. Breakthrough cancer pain. Curr Pain Headache Rep 2014;18:420.   DOI
19 Mercadante S. Pharmacotherapy for breakthrough cancer pain. Drugs 2012;72:181-90.   DOI
20 Davies A, Buchanan A, Zeppetella G, Porta-Sales J, Likar R, Weismayr W, et al. Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage 2013;46:619-28.   DOI
21 Bedard G, Davies A, McDonald R, Hawley P, Buchanan A, Popovic M, et al. Breakthrough cancer pain: a comparison of surveys with European and Canadian patients. Support Care Cancer 2015;23:791-6.   DOI
22 Zeppetella G. Dynamics of breakthrough pain vs. pharmacokinetics of oral morphine: implications for management. Eur J Cancer Care (Engl) 2009;18:331-7.   DOI
23 Zeppetella G. Impact and management of breakthrough pain in cancer. Curr Opin Support Palliat Care 2009;3:1-6.   DOI
24 Mercadante S, Villari P, Casuccio A. An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer 2011;19:979-83.   DOI
25 Shin DW, Choi JY, Nam BH, Seo WS, Kim HY, Hwang EJ, et al. The Current Status of Utilization of Palliative Care Units in Korea: 6 month results of 2009 Korean Terminal Cancer Patient Information System. Korean J Hosp Palliat Care 2010;13:181-9.
26 Lee MA, Yeom CH, Choi YS, Jang SK, Park JN, Song CH, et al. The frequency and distress score of symptom of cancer patients - for the development of Korean Cancer Pain Assessment Tool (K-CPAT). Korean J Hosp Palliat Care 2003;6:45-50.
27 Koh SJ, Lee KS, Hong YS, Yoo YS, Park HJ. Clinical Change of Terminally Ill Cancer Patients at the End-of-life Time. Korean J Hosp Palliat Care 2008;11:99-105.
28 Stanley TH. The Fentanyl Story. J Pain 2014;15:1215-26.   DOI
29 Smith HS. Considerations in selecting rapid-onset opioids for the management of breakthrough pain. J Pain Res 2013;6:189-200.
30 Rustoen T, Geerling JI, Pappa T, Rundstrom C, Weisse I, Williams SC, et al. A European survey of oncology nurse breakthrough cancer pain practices. Eur J Oncol Nurs 2013;17:95-100.   DOI